Faculty of Medicine (D.R.F., P.R.P.), University of Lisbon, Lisboa, Portugal.
Faculty of Medicine (D.R.F., P.R.P.), University of Lisbon, Lisboa, Portugal; Bento Menni Palliative Care Unit (P.R.P.), Sintra, Portugal.
J Pain Symptom Manage. 2024 Nov;68(5):e356-e372. doi: 10.1016/j.jpainsymman.2024.07.005. Epub 2024 Aug 3.
Home-Based Palliative Care (HPC) interventions have emerged as a promising approach to deliver patient-centered care in familiar surroundings, aligning with patients' preferences and improving quality of life (QOL).
This review aimed to systematically assess the impact of HPC interventions on symptom management, QOL, healthcare resource utilization and place of death among patients with severe, progressive illnesses requiring end-of-life care.
A comprehensive search was conducted across PubMed, Cochrane, and Scopus databases to identify relevant studies published between January 1, 2013, and December 31, 2023. Eligible studies included randomized controlled trials and clinical studies evaluating the effectiveness of HPC interventions compared to usual care. Risk of bias assessment was performed using Cochrane tools.
Nine publications meeting inclusion criteria were identified. Findings indicate that HPC interventions, delivered by specialized teams or integrated care approaches, significantly improve QOL and increase the likelihood of patients dying at home. Moreover, HPC is associated with reduced healthcare utilization, including fewer hospital admissions, emergency department visits, and shorter hospital stays. No significant differences were observed in symptom management.
HPC interventions demonstrate significant benefits in addressing the complex needs of patients with advanced illnesses. These findings underscore the importance of integrating HPC into healthcare systems to optimize outcomes and promote quality end-of-life care. Future research should focus on expanding access to HPC services, enhancing interdisciplinary collaboration, and incorporating patient preferences to further improve care delivery in this vulnerable population.
家庭为基础的姑息治疗(HPC)干预措施已成为一种有前途的方法,可以在熟悉的环境中提供以患者为中心的护理,符合患者的偏好并提高生活质量(QOL)。
本综述旨在系统评估 HPC 干预措施对需要临终关怀的严重、进行性疾病患者的症状管理、QOL、医疗资源利用和死亡地点的影响。
在 PubMed、Cochrane 和 Scopus 数据库中进行全面检索,以确定 2013 年 1 月 1 日至 2023 年 12 月 31 日期间发表的相关研究。纳入标准为评估 HPC 干预措施与常规护理相比有效性的随机对照试验和临床研究。使用 Cochrane 工具进行偏倚风险评估。
确定了 9 篇符合纳入标准的出版物。研究结果表明,由专业团队或综合护理方法提供的 HPC 干预措施可显著提高 QOL,并增加患者在家中死亡的可能性。此外,HPC 与减少医疗保健利用相关,包括减少住院、急诊就诊和缩短住院时间。在症状管理方面未观察到显著差异。
HPC 干预措施在满足晚期疾病患者的复杂需求方面显示出显著的益处。这些发现强调了将 HPC 纳入医疗保健系统以优化结果并促进优质临终关怀的重要性。未来的研究应侧重于扩大 HPC 服务的获取途径,加强跨学科合作,并纳入患者偏好,以进一步改善这一脆弱人群的护理提供。